Highlights from ASCO-GI 2021 from EORTC Gastrointestinal tract cancer group.
Détails
Etat: Public
Version: Final published version
Licence: CC BY 4.0
ID Serval
serval:BIB_9EA83BC830BF
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Institution
Titre
Highlights from ASCO-GI 2021 from EORTC Gastrointestinal tract cancer group.
Périodique
British journal of cancer
ISSN
1532-1827 (Electronic)
ISSN-L
0007-0920
Statut éditorial
Publié
Date de publication
09/2021
Peer-reviewed
Oui
Volume
125
Numéro
7
Pages
911-919
Langue
anglais
Notes
Publication types: Journal Article ; Review
Publication Status: ppublish
Publication Status: ppublish
Résumé
Last year the field of immunotherapy was finally introduced to GI oncology, with several changes in clinical practice such as advanced hepatocellular carcinoma or metastatic colorectal MSI-H. At the virtual ASCO-GI symposium 2021, several large trial results have been reported, some leading to a change of practice. Furthermore, during ASCO-GI 2021, results from early phase trials have been presented, some with potential important implications for future treatments. We provide here an overview of these important results and their integration into routine clinical practice.
Pubmed
Web of science
Open Access
Oui
Création de la notice
03/09/2021 17:59
Dernière modification de la notice
12/01/2022 8:12